Was Kaye Jack’s uniQure (QURE) share sale made under a Rule 10b5-1 plan?

Yes. The filing states the transactions were executed under a sales plan adopted on June 16, 2025 and intended to comply with Rule 10b5-1. Such pre-arranged plans schedule trades in advance, reducing the significance of trade timing as a discretionary signal.

What happened to Kaye Jack’s stock option related to 2,645 uniQure (QURE) shares?

The stock option for 2,645 Ordinary Shares, which vested fully on February 24, 2023, was exercised on June 3, 2026. After this exercise, the filing shows zero remaining shares under that specific option, indicating the award was fully used.

uniQure director sells 2,645 shares after exercise

uniQure N.V. director Kaye Jack reported an option exercise paired with a share sale.

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

uniQure N.V. director Kaye Jack reported an option exercise paired with a share sale. On June 3, 2026, Jack exercised stock options to acquire 2,645 Ordinary Shares at $16.04 per share and sold 2,645 Ordinary Shares in open-market transactions at an average price of $30.01 per share. These transactions were made under a pre-arranged Rule 10b5-1 trading plan adopted on June 16, 2025. After the trades, Jack directly owned 20,439 Ordinary Shares, and the exercised stock option for 2,645 shares, which had vested in full on February 24, 2023, was fully used.

Insider Trade Summary 10b5-1

Exercise and Sale: 2,645 shares ($37K approx. pre-tax spread)

Exercise and Sale 3 txns

Insider Kaye Jack

Role Director

Sold 2,645 shs ($79K)

Approx. gross sale proceeds $79K

Approx. exercise cost $42K

Approx. pre-tax spread $37K

Type	Security	Shares	Price	Value
Exercise	Stock Option (Right to Buy)	2,645	$0.00	$0.00
Exercise	Ordinary Shares	2,645	$16.04	$42K
Sale	Ordinary Shares	2,645	$30.01	$79K

Holdings After Transaction: Stock Option (Right to Buy) — 0 contracts (Direct); Ordinary Shares — 20,439 shares (Direct)

Footnotes (2)

F1. The transactions reported herein were effected pursuant to a sales plan adopted by the Reporting Person on June 16, 2025 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934.
F2. The Stock Option vested in full on February 24, 2023.

Key Figures

Shares sold: 2,645 Ordinary Shares Sale price: $30.01 per share Option exercise price: $16.04 per share +4 more

7 metrics

Shares sold 2,645 Ordinary Shares Open-market sale on June 3, 2026

Sale price $30.01 per share Average sale price for 2,645 shares

Option exercise price $16.04 per share Exercise price for 2,645-share stock option

Shares after transactions 20,439 Ordinary Shares Direct holdings following June 3, 2026 trades

Net shares sold 2,645 shares Net sell direction from transaction summary

Option expiration February 24, 2032 Expiration date for exercised stock option grant

Option vesting date February 24, 2023 Stock option vested in full on this date

Key Terms

Rule 10b5-1, Stock Option (Right to Buy), Ordinary Shares, open-market sale, +1 more

5 terms

Rule 10b5-1 regulatory

"intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934"

Rule 10b5-1 is a regulation that allows company insiders to buy or sell their shares at predetermined times, even if they have access to non-public information. It acts like setting a schedule in advance for transactions, helping prevent accusations of unfair trading. This rule provides a way for insiders to plan trades transparently, giving investors confidence that these transactions are not based on hidden information.

Stock Option (Right to Buy) financial

"security_title": "Stock Option (Right to Buy)""

Ordinary Shares financial

"security_title": "Ordinary Shares""

Ordinary shares are a type of ownership stake in a company, giving shareholders a right to participate in the company’s profits and decision-making through voting. They are similar to owning a piece of a business, and their value can rise or fall based on the company's performance. Investors buy ordinary shares to potentially earn dividends and benefit from the company's growth over time.

open-market sale financial

"transaction_action": "open-market sale""

An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.

derivative exercise/conversion financial

"transaction_action": "derivative exercise/conversion""

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Kaye Jack report at uniQure (QURE)?

Kaye Jack reported exercising stock options for 2,645 Ordinary Shares and selling 2,645 Ordinary Shares in open-market trades. The sale price averaged $30.01 per share, while the option exercise price was $16.04 per share, reflecting an exercise-and-sell pattern.

When did the latest uniQure (QURE) insider transactions by Kaye Jack occur?

The reported insider transactions occurred on June 3, 2026. On that date, Kaye Jack exercised stock options and sold 2,645 Ordinary Shares in the market, all under a pre-established Rule 10b5-1 trading plan adopted on June 16, 2025.

How many uniQure (QURE) shares does Kaye Jack hold after the transactions?

Following the June 3, 2026 transactions, Kaye Jack directly holds 20,439 Ordinary Shares of uniQure N.V. This figure reflects holdings after exercising options for 2,645 shares and selling 2,645 shares in open-market transactions reported in the Form 4 filing.

At what prices did Kaye Jack exercise and sell uniQure (QURE) shares?

Kaye Jack exercised stock options at an exercise price of $16.04 per Ordinary Share and sold 2,645 Ordinary Shares at an average price of $30.01 per share. This combination shows conversion of options into shares followed by open-market sales on the same date.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Accepted by SEC EDGAR 06/05/2026 - 04:43 PM EDT

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Kaye Jack

(Last)

(First)

(Middle)

C/O UNIQURE N.V.

PAASHEUVELWEG 25A

(Street)

AMSTERDAM

1105BP

(City)

(State)

(Zip)

NETHERLANDS

(Country)

2. Issuer Name and Ticker or Trading Symbol
uniQure N.V. [ QURE ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/03/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Ordinary Shares	06/03/2026		M⁽¹⁾		2,645	A	$16.04	23,084	D
Ordinary Shares	06/03/2026		S⁽¹⁾		2,645	D	$30.01	20,439	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Stock Option (Right to Buy)	$16.04	06/03/2026		M⁽¹⁾			2,645	⁽²⁾	02/24/2032	Ordinary Shares	2,645	$0	0	D

Explanation of Responses:

1. The transactions reported herein were effected pursuant to a sales plan adopted by the Reporting Person on June 16, 2025 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934.

2. The Stock Option vested in full on February 24, 2023.

	/s/ Christian Klemt, Attorney-in-Fact	06/05/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR